(Q39340367)

English

Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro

scientific article published on 27 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B A Kamen

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A K Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

27 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

113-120

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Folate-mediated one-carbon metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Folate-targeted chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Farletuzumab in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Emerging role of pemetrexed in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Receptor-mediated folate accumulation is regulated by the cellular folate content

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Endocytosis of lipid-anchored proteins: excluding GEECs from the crowd

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Renal tubular reabsorption of folate mediated by folate binding protein 1.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

PMA alters folate receptor distribution in the plasma membrane and increases the rate of 5-methyltetrahydrofolate delivery in mature MA104 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1890-2

21 January 2018

Identifiers

10.1007/S00280-012-1890-2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39340367&oldid=2202792586"